FDA Gives Thumbs Up to New Cancer Treatment: Say Hello to Ziihera-zanidatamab-hrii for Unresectable Biliary Tract Cancer!

Welcome to the World of Ziihera® – A Quirky New Approach to Cancer Treatment Breaking News: Zymeworks Inc. and Jazz Pharmaceuticals Make Waves with Ziihera® Approval Hey there, fellow health enthusiasts and curious minds! Have you heard the buzz about Ziihera®? If not, let me fill you in on the latest and greatest news in…

Read More

“Attention Investors: Former Louisiana Attorney General Investigates Sale of Staffing 360 Solutions Inc. – Is the Price and Process Adequate?”

The Impact of Staffing 360 Solutions, Inc. Sale on Shareholders Investigation by Charles C. Foti, Jr., Esq. and Kahn Swick & Foti, LLC NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Staffing 360 Solutions,…

Read More

Unpacking Broadcom Inc.’s Q4 2024 Earnings Call: A Deep Dive into the Future of AVGO

Broadcom Inc. recently held their Q4 2024 Earnings Conference Call on December 12, 2024, at 5:00 PM ET. The call featured key company executives such as Hock Tan, President & CEO, and Kirsten Spears, CFO. In addition, there were several notable conference call participants, including analysts from firms like Jefferies, Cantor Fitzgerald, and Morgan Stanley….

Read More

Abbvie Receives European Commission Approval for Elahere (Mirvetuximab Soravtansine) in Platinum-Resistant Ovarian Cancer Treatment

Exciting News for Ovarian Cancer Patients in the EU Introduction ELAHERE is making waves in the medical community as the first novel therapy approved in the European Union specifically for patients with folate receptor-alpha (FRα) positive, platinum-resistant ovarian cancer. This groundbreaking treatment has shown promising results in a Phase 3 trial, demonstrating an overall survival…

Read More